Clinical Trial Update: PD-1 Inhibitors Maintenance for cHL Post-autoHCT [Phase 2]

View source ↗

Summary

Phase 2 trial assessing maintenance PD-1 inhibitors in classical Hodgkin lymphoma after autologous stem cell transplant; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: St. Petersburg State Pavlov Medical University | Conditions: Hodgkin Lymphoma | Phase 2 | Status: RECRUITING